Regulation of AGR2 expression via 3'UTR shortening (Q51059812)

27 March 2018

title

Regulation of AGR2 expression via 3'UTR shortening (English)

1 reference

27 March 2018

4

Borivoj Vojtesek

1 reference

27 March 2018

author name string

Eva Matoulkova

1

1 reference

27 March 2018

Lucia Sommerova

2

1 reference

27 March 2018

Michal Pastorek

3

1 reference

27 March 2018

Roman Hrstka

5

1 reference

27 March 2018

language of work or name

English

0 references

publication date

10 April 2017

1 reference

27 March 2018

Experimental Cell Research

published in

1 reference

27 March 2018

volume

356

1 reference

27 March 2018

issue

1

1 reference

27 March 2018

page(s)

40-47

1 reference

27 March 2018

The role of the 3' untranslated region in post-transcriptional regulation of protein expression in mammalian cells

cites work

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

Regulation of eukaryotic gene expression by the untranslated gene regions and other non-coding elements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

MicroRNA history: discovery, recent applications, and next frontiers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

The expression of HMGA genes is regulated by their 3'UTR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

The tumor suppressor microRNA let-7 represses the HMGA2 oncogene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

3'UTR mediated regulation of the cyclin D1 proto-oncogene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

Impaired pre-mRNA processing and altered architecture of 3' untranslated regions contribute to the development of human disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

Emerging roles for the pro-oncogenic anterior gradient-2 in cancer development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

Anterior gradient protein-2 is a regulator of cellular adhesion in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

The estrogen-responsive Agr2 gene regulates mammary epithelial proliferation and facilitates lobuloalveolar development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

Anterior gradient 2 (AGR2): blood-based biomarker elevated in metastatic prostate cancer associated with the neuroendocrine phenotype.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

Aberrant hypomethylation-mediated AGR2 overexpression induces an aggressive phenotype in ovarian cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

Expression of AGR2 in pituitary adenomas and its association with tumor aggressiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

Proteomic study explores AGR2 as pro-metastatic protein in HCC.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

High expression of AGR2 in lung cancer is predictive of poor survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

Anterior gradient protein 2 promotes survival, migration and invasion of papillary thyroid carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

AGR2 oncoprotein inhibits p38 MAPK and p53 activation through a DUSP10-mediated regulatory pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

AGR2 is associated with gastric cancer progression and poor survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

Splice variant transcripts of the anterior gradient 2 gene as a marker of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

The Ensembl genome database project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

Progressive lengthening of 3' untranslated regions of mRNAs by alternative polyadenylation during mouse embryonic development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

The human genome browser at UCSC

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

mRNA 3'-UTR shortening is a molecular signature of mTORC1 activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

Identification of an AKT-dependent signalling pathway that mediates tamoxifen-dependent induction of the pro-metastatic protein anterior gradient-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

The involvement of anterior gradient 2 in the stromal cell-derived factor 1-induced epithelial-mesenchymal transition of glioblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

Secretion of protein disulphide isomerase AGR2 confers tumorigenic properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

Binding of anterior gradient 2 and estrogen receptor-α: Dual critical roles in enhancing fulvestrant resistance and IGF-1-induced tumorigenesis of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

Agr2 mediates paracrine effects on stromal fibroblasts that promote invasion by gastric signet-ring carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

Estrogen-induced upregulation and 3'-UTR shortening of CDC6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

PI3K and cancer: lessons, challenges and opportunities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

Physiological stress induces the metastasis marker AGR2 in breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

Induction of anterior gradient 2 (AGR2) plays a key role in insulin-like growth factor-1 (IGF-1)-induced breast cancer cell proliferation and migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

A unifying model for mTORC1-mediated regulation of mRNA translation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

The TSC-mTOR pathway mediates translational activation of TOP mRNAs by insulin largely in a raptor- or rictor-independent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

An enhanced computational platform for investigating the roles of regulatory RNA and for identifying functional RNA motifs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

To localize or not to localize: mRNA fate is in 3'UTR ends

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.04.011

10.1016/J.YEXCR.2017.04.011

7 January 2021

Identifiers

DOI

1 reference

27 March 2018

1 reference

27 March 2018